Ombitasvir, paritaprevir, ritonavir and dasabuvir and Oritavancin Intravenous
Determining the interaction of Ombitasvir, paritaprevir, ritonavir and dasabuvir and Oritavancin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
Generic Name: oritavancin
Brand name: Orbactiv
Synonyms: Oritavancin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Orkambi
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Orkambi (Lumacaftor and Ivacaftor Granules)
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Orkambi (Lumacaftor and Ivacaftor Tablets)
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Orlistat
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Ornex
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Ornex Maximum Strength
- Oritavancin Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Oritavancin Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Oritavancin Intravenous-Omeclamox-Pak
- Oritavancin Intravenous-Omega-3 Fatty Acid Capsules
- Oritavancin Intravenous-Omega-3 Fatty Acids
- Oritavancin Intravenous-Omega-3 polyunsaturated fatty acids